MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine, covering 2014-06-12 to 2014-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects [Phase 3]